It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for obesity New platform partnerships wit ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...